Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J R Arrand

Showing results (71-80 of 85) with videos related to

Pageof 9
Sort By:
Vaccine|January 1, 1992
Purification and characterization of Epstein-Barr virus gp340/220 produced by a bovine papillomavirus virus expression vector systemM Madej, M J Conway, A J Morgan, et al.
Virology|April 20, 1995
Antigenic and sequence variation in the C-terminal unique domain of the Epstein-Barr virus nuclear antigen EBNA-1M N Wrightham, J P Stewart, N J Janjua, et al.
The EMBO Journal|August 1, 1986
Identification of an Epstein-Barr virus-coded thymidine kinaseE Littler, J Zeuthen, A A McBride, et al.
International Journal of Cancer|February 20, 1993
Serological response to HPV 16 in cervical dysplasia and neoplasia: correlation of antibodies to E6 with cervical cancerA K Ghosh, N K Smith, S N Stacey, et al.
Cancer Gene Therapy|June 8, 1999
Antigen gene transfer to cultured human dendritic cells using recombinant avipoxvirus vectorsM Brown, D H Davies, M A Skinner, et al.
Journal of Virology|June 1, 1996
Identification and characterization of murine gammaherpesvirus 68 gp150: a virion membrane glycoproteinJ P Stewart, N J Janjua, S D Pepper, et al.
The Journal of General Virology|April 1, 1987
Epstein-Barr virus-specific transcription in normal and malignant nasopharyngeal biopsies and in lymphocytes from healthy donors and infectious mononucleosis patientsJ D Tugwood, W H Lau, S K O, et al.
Thorax|November 1, 1996
Epstein-Barr virus associated graft failure following heart/lung transplantationJ J Egan, J P Stewart, P S Hasleton, et al.
British Journal of Cancer|January 1, 1997
Differences in serological IgA responses to recombinant baculovirus-derived human papillomavirus E2 protein in the natural history of cervical neoplasiaL Rocha-Zavaleta, D Jordan, S Pepper, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 1, 1990
Human cytotoxic T-cell responses against Epstein-Barr virus nuclear antigens demonstrated by using recombinant vaccinia virusesR J Murray, M G Kurilla, H M Griffin, et al.
Pageof 9

Showing results (71-80 of 85) with videos related to

Sort By:
Pageof 9
Vaccine|January 1, 1992
Purification and characterization of Epstein-Barr virus gp340/220 produced by a bovine papillomavirus virus expression vector systemM Madej, M J Conway, A J Morgan, et al.
Virology|April 20, 1995
Antigenic and sequence variation in the C-terminal unique domain of the Epstein-Barr virus nuclear antigen EBNA-1M N Wrightham, J P Stewart, N J Janjua, et al.
The EMBO Journal|August 1, 1986
Identification of an Epstein-Barr virus-coded thymidine kinaseE Littler, J Zeuthen, A A McBride, et al.
International Journal of Cancer|February 20, 1993
Serological response to HPV 16 in cervical dysplasia and neoplasia: correlation of antibodies to E6 with cervical cancerA K Ghosh, N K Smith, S N Stacey, et al.
Cancer Gene Therapy|June 8, 1999
Antigen gene transfer to cultured human dendritic cells using recombinant avipoxvirus vectorsM Brown, D H Davies, M A Skinner, et al.
Journal of Virology|June 1, 1996
Identification and characterization of murine gammaherpesvirus 68 gp150: a virion membrane glycoproteinJ P Stewart, N J Janjua, S D Pepper, et al.
The Journal of General Virology|April 1, 1987
Epstein-Barr virus-specific transcription in normal and malignant nasopharyngeal biopsies and in lymphocytes from healthy donors and infectious mononucleosis patientsJ D Tugwood, W H Lau, S K O, et al.
Thorax|November 1, 1996
Epstein-Barr virus associated graft failure following heart/lung transplantationJ J Egan, J P Stewart, P S Hasleton, et al.
British Journal of Cancer|January 1, 1997
Differences in serological IgA responses to recombinant baculovirus-derived human papillomavirus E2 protein in the natural history of cervical neoplasiaL Rocha-Zavaleta, D Jordan, S Pepper, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 1, 1990
Human cytotoxic T-cell responses against Epstein-Barr virus nuclear antigens demonstrated by using recombinant vaccinia virusesR J Murray, M G Kurilla, H M Griffin, et al.
Pageof 9